Showing results (251-260 of 305) with videos related to
Sort By:
Pageof 31
Annals of Neurology|May 1, 1988
Mild senile dementia of the Alzheimer type: 2. Longitudinal assessmentL Berg, J P Miller, M Storandt, et al.Neurology|December 13, 2000
Early DAT is distinguished from aging by high-dimensional mapping of the hippocampus. Dementia of the Alzheimer typeJ G Csernansky, L Wang, S Joshi, et al.Neurology|April 1, 1991
Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal agingJ C Morris, D W McKeel, M Storandt, et al.International Journal of Geriatric Psychiatry|July 24, 2001
Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success?B Winblad, H Brodaty, S Gauthier, et al.Archives of Neurology|January 1, 1988
Reliability of the Washington University Clinical Dementia RatingW J Burke, J P Miller, E H Rubin, et al.Human Gene Therapy|January 1, 1996
In vitro assessment of variables affecting the efficiency and efficacy of adenovirus-mediated gene transfer to cystic fibrosis airway epitheliaL G Johnson, R J Pickles, S E Boyles, et al.Neurology|July 1, 1997
The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD Study. Consortium to Establish a Registry for Alzheimer's DiseaseC M Clark, D Ewbank, A Lerner, et al.Journal of Geriatric Psychiatry and Neurology|October 1, 1996
Clinical evaluation of global change in Alzheimer's disease: identifying consensusJ T Olin, L S Schneider, R S Doody, et al.Endocrinology|March 1, 1994
Thyrotropin (TSH) interacts with multiple discrete regions of the TSH receptor: polyclonal rabbit antibodies to one or more of these regions can inhibit TSH binding and functionJ S Dallas, R K Desai, S J Cunningham, et al.Alzheimer Disease and Associated Disorders|September 15, 1999
Clinical trials in Alzheimer disease: debate on the use of placebo controlsC H Kawas, C M Clark, M R Farlow, et al.Pageof 31